Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan 1;203(1):144-145.
doi: 10.1164/rccm.202008-3040LE.

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

Cheng-Yi Wang  1 , Chih-Cheng Lai  2
Affiliations
Comment

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

Cheng-Yi Wang et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Han MK, Criner GJ, Dransfield MT, Halpin DMG, Jones CE, Kilbride S, et al. The effect of ICS withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study: a randomized, double-blind multicenter trial. Am J Respir Crit Care Med. [online ahead of print] 25 Jun 2020; DOI: 10.1164/rccm.201912-2478OC. - PMC - PubMed
    1. Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, et al. IMPACT Investigators. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378:1671–1680. - PubMed
    1. Chalmers JD, Laska IF, Franssen FME, Janssens W, Pavord I, Rigau D, et al. Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline. Eur Respir J. 2020;55:2000351. - PubMed
    1. Wouters EFM, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, et al. COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax. 2005;60:480–487. - PMC - PubMed
    1. Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, et al. WISDOM Investigators. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med. 2014;371:1285–1294. - PubMed

Substances